CG
TWST icon

Caprock Group’s Twist Bioscience TWST Stock Holding History

Caprock Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$869K Buy
8,447
+2,327
+38% +$151K 0.02% 671
2026
Q1 		$291K Buy
+6,120
New +$274K 0.01% 930
2025
Q1 		$344K Buy
8,757
+839
+11% +$37.8K 0.01% 836
2024
Q4 		$368K Buy
7,918
+71
+0.9% +$3.21K 0.01% 726
2024
Q3 		$355K Sell
7,847
-4
-0.1% -$190 0.01% 670
2024
Q2 		$387K Buy
7,851
+220
+3% +$8.97K 0.02% 615
2024
Q1 		$262K Sell
7,631
-10
-0.1% -$361 0.02% 602
2023
Q4 		$282K Buy
+7,641
New +$177K 0.02% 550

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Caprock Group's TWST Position: Q2 2026 in Review

Caprock Group increased its Twist Bioscience (TWST) stake by 38% in Q2 2026, buying an estimated $151K and bringing the position to 8,447 shares worth $869K. The position accounts for 0.02% of the portfolio, ranked #671.

Caprock Group first reported a position in TWST in Q4 2023 and has held it in 8 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Caprock Group held 8,447 shares of Twist Bioscience worth $869K as of Q2 2026.
  • Caprock Group bought 2,327 Twist Bioscience shares in Q2 2026, an estimated $151K.
  • Twist Bioscience made up 0.02% of Caprock Group's portfolio in Q2 2026, its #671 holding.
  • Caprock Group first reported a position in Twist Bioscience in Q4 2023 and has held it in 8 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.